Elisabet De Los Pinos

Elisabet de los Pinos is the Founder and CEO of Aura Biosciences, a clinical-stage oncology company established in January 2010, specializing in developing virus-like drug conjugates (VDCs) for targeted cancer treatment and immune system activation. Prior to this role, Elisabet served as Brand Manager for the Oncology Business Unit at Eli Lilly from January 2003 to 2006. Educational qualifications include an MBA in Management from the MIT Sloan School of Management in 2008, an MBA from IE Business School in 2002, a Ph.D. in Molecular and Cell Biology from The Institute of Cancer Research between 2000 and 2002, and undergraduate studies at Universitat de Barcelona from 1995 to 2000, with additional coursework at the Icahn School of Medicine at Mount Sinai in 1999.